Sanjeev Satyal 피에이치파마 R&D 총괄美선 최신 바이오 트렌드 적용한국선 신약후보 기초 연구녹내장·지방간염 치료제 개발 중(자세한 기사 전문은 아래 링크 참조해주시기 바랍니다)https://www.hankyung.com/it/article/202003033648i
pH Pharma Develops New Drugs through Synergy between US and Korea
Sanjeev Satyal, Head of R&D of pH PhamaImplement new technology and culture from U.S.Basic research for new drug candidate in KoreaDeveloping glaucoma and NASH treatments(For more information, please refer to the link below)https://www.hankyung.com/it/article/202003033648i